- GeoVax Labs filed notice it will miss deadline for annual report on Form 10-K for fiscal year ended Dec. 31, 2025.
- Filing, originally due March 31, 2026, was delayed by work needed to compile and review information for report.
- GeoVax expects to file Form 10-K within 15-day extension period under SEC rules.
- Results are expected to show net loss of about $22 million for 2025 versus $25 million in 2024.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeoVax Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-010722), on March 31, 2026, and is solely responsible for the information contained therein.
Comments